These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

490 related items for PubMed ID: 12375318

  • 1. "5D" Outcome in 52 patients with rheumatoid arthritis surviving 20 years after initial disease modifying antirheumatic drug therapy.
    Capell H, McCarey D, Madhok R, Hampson R.
    J Rheumatol; 2002 Oct; 29(10):2099-105. PubMed ID: 12375318
    [Abstract] [Full Text] [Related]

  • 2. A 10 year prospective followup of patients with rheumatoid arthritis 1986-96.
    Gordon P, West J, Jones H, Gibson T.
    J Rheumatol; 2001 Nov; 28(11):2409-15. PubMed ID: 11708411
    [Abstract] [Full Text] [Related]

  • 3. Patient, disease, and therapy-related factors that influence discontinuation of disease-modifying antirheumatic drugs: a population-based incidence cohort of patients with rheumatoid arthritis.
    Maradit-Kremers H, Nicola PJ, Crowson CS, O'Fallon WM, Gabriel SE.
    J Rheumatol; 2006 Feb; 33(2):248-55. PubMed ID: 16358365
    [Abstract] [Full Text] [Related]

  • 4. Therapeutic strategies in rheumatoid arthritis over a 40-year period.
    Kremers HM, Nicola P, Crowson CS, O'Fallon WM, Gabriel SE.
    J Rheumatol; 2004 Dec; 31(12):2366-73. PubMed ID: 15570636
    [Abstract] [Full Text] [Related]

  • 5. The methotrexate therapeutic response in rheumatoid arthritis.
    Ortendahl M, Holmes T, Schettler JD, Fries JF.
    J Rheumatol; 2002 Oct; 29(10):2084-91. PubMed ID: 12375316
    [Abstract] [Full Text] [Related]

  • 6. High dose chemotherapy and hematopoietic stem cell transplantation: a study of treatment preference in patients with rheumatoid arthritis and rheumatologists.
    Verburg RJ, Mahabali SD, Stiggelbout AM, Sont JK, van Laar JM.
    J Rheumatol; 2002 Aug; 29(8):1653-8. PubMed ID: 12180724
    [Abstract] [Full Text] [Related]

  • 7. Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritis.
    Welsing PM, Fransen J, van Riel PL.
    Arthritis Rheum; 2005 Sep; 52(9):2616-24. PubMed ID: 16142762
    [Abstract] [Full Text] [Related]

  • 8. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial.
    Puolakka K, Kautiainen H, Möttönen T, Hannonen P, Korpela M, Julkunen H, Luukkainen R, Vuori K, Paimela L, Blåfield H, Hakala M, Leirisalo-Repo M.
    Arthritis Rheum; 2004 Jan; 50(1):55-62. PubMed ID: 14730599
    [Abstract] [Full Text] [Related]

  • 9. Rheumatoid factor by laser nephelometry and Waaler-Rose assay: prognostic value in patients with recent-onset rheumatoid arthritis.
    Nikolaisen C, Rekvig OP, Nossent HC.
    Scand J Rheumatol; 2005 Jan; 34(4):269-76. PubMed ID: 16195159
    [Abstract] [Full Text] [Related]

  • 10. Prediction of mortality in rheumatoid arthritis based on disease activity markers.
    Book C, Saxne T, Jacobsson LT.
    J Rheumatol; 2005 Mar; 32(3):430-4. PubMed ID: 15742433
    [Abstract] [Full Text] [Related]

  • 11. Autoantibodies in early seropositive rheumatoid arthritis, before and during disease modifying antirheumatic drug treatment.
    Paulus HE, Wiesner J, Bulpitt KJ, Patnaik M, Law J, Park GS, Wong WK.
    J Rheumatol; 2002 Dec; 29(12):2513-20. PubMed ID: 12465144
    [Abstract] [Full Text] [Related]

  • 12. Intention-to-treat analysis of 200 patients with rheumatoid arthritis 12 years after random allocation to either sulfasalazine or penicillamine.
    Capell HA, Maiden N, Madhok R, Hampson R, Thomson EA.
    J Rheumatol; 1998 Oct; 25(10):1880-6. PubMed ID: 9779839
    [Abstract] [Full Text] [Related]

  • 13. Evaluation and documentation of rheumatoid arthritis disease status in the clinic: which variables best predict change in therapy.
    Wolfe F, Pincus T, O'Dell J.
    J Rheumatol; 2001 Jul; 28(7):1712-7. PubMed ID: 11469486
    [Abstract] [Full Text] [Related]

  • 14. Longterm methotrexate use in rheumatoid arthritis: 12 year followup of 460 patients treated in community practice.
    Wluka A, Buchbinder R, Mylvaganam A, Hall S, Harkness A, Lewis D, Littlejohn GO, Miller MH, Ryan PF.
    J Rheumatol; 2000 Aug; 27(8):1864-71. PubMed ID: 10955325
    [Abstract] [Full Text] [Related]

  • 15. Factors influencing length of time taking methotrexate in rheumatoid arthritis.
    Ortendahl M, Schettler JD, Fries JF.
    J Rheumatol; 2000 May; 27(5):1139-47. PubMed ID: 10813279
    [Abstract] [Full Text] [Related]

  • 16. Efficient management of rheumatoid arthritis significantly reduces long-term functional disability.
    Tanaka E, Mannalithara A, Inoue E, Hara M, Tomatsu T, Kamatani N, Singh G, Yamanaka H.
    Ann Rheum Dis; 2008 Aug; 67(8):1153-8. PubMed ID: 17971459
    [Abstract] [Full Text] [Related]

  • 17. Rheumatoid arthritis: workload and outcome over 10 years.
    Capell HA, Murphy EA, Hunter JA.
    Q J Med; 1991 Jun; 79(290):461-76. PubMed ID: 1946927
    [Abstract] [Full Text] [Related]

  • 18. Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis: relative area under the curve effectiveness and sequence effects.
    Hurst S, Kallan MJ, Wolfe FJ, Fries JF, Albert DA.
    J Rheumatol; 2002 Aug; 29(8):1639-45. PubMed ID: 12180722
    [Abstract] [Full Text] [Related]

  • 19. What factors influence functional ability in patients with rheumatoid arthritis. Do they alter over time?
    Plant MJ, O'Sullivan MM, Lewis PA, Camilleri JP, Coles EC, Jessop JD.
    Rheumatology (Oxford); 2005 Sep; 44(9):1181-5. PubMed ID: 15972357
    [Abstract] [Full Text] [Related]

  • 20. Community-based evaluation of etanercept in patients with rheumatoid arthritis.
    Farahani P, Levine M, Gaebel K, Wang EC, Khalidi N.
    J Rheumatol; 2006 Apr; 33(4):665-70. PubMed ID: 16568506
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.